These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 16166486)
1. Pediatric medicine. Europe follows U.S. in testing drugs for children. Bosch X Science; 2005 Sep; 309(5742):1799. PubMed ID: 16166486 [No Abstract] [Full Text] [Related]
2. EU law mandates drug testing in children. Sinha G J Natl Cancer Inst; 2008 Jan; 100(2):84-5. PubMed ID: 18182609 [No Abstract] [Full Text] [Related]
3. The Best Pharmaceuticals for Children Act of 2002: the rise of the voluntary incentive structure and congressional refusal to require pediatric testing. Breslow LH Harvard J Legis; 2003; 40(1):133-93. PubMed ID: 16594116 [TBL] [Abstract][Full Text] [Related]
4. EMEA tackles "generic" biologic drug issues. Rice M J Natl Cancer Inst; 2006 Apr; 98(7):435-6. PubMed ID: 16595776 [No Abstract] [Full Text] [Related]
5. [European network for investigation of medicinal products in children (Medichildren)]. Pons G Arch Pediatr; 2006 Jun; 13(6):631. PubMed ID: 16713209 [No Abstract] [Full Text] [Related]
6. [Network for investigation of medicinal products in children]. Kassaï B; Treluyer JM; Jacqz-Aigrain E; Pons G Arch Pediatr; 2006 Jun; 13(6):631-4. PubMed ID: 16697606 [No Abstract] [Full Text] [Related]
7. The evolution of legislation to regulate pediatric clinical trials: Present and continuing challenges. Gans-Brangs KR; Plourde PV Adv Drug Deliv Rev; 2006 Apr; 58(1):106-15. PubMed ID: 16530291 [TBL] [Abstract][Full Text] [Related]
8. The march toward rational therapeutics in children. Gorman RL Pediatr Infect Dis J; 2003 Dec; 22(12):1119-23. PubMed ID: 14688584 [TBL] [Abstract][Full Text] [Related]
9. [The Medical Products Agency's preparations prior to the new EU regulation on children and drugs]. Johannesson M; Berglund EG Lakartidningen; 2007 Jul 11-24; 104(28-29):2099. PubMed ID: 17702388 [No Abstract] [Full Text] [Related]
10. [New guidelines of the European Union. Motivation for drug testing in pediatrics]. Appel K Dtsch Med Wochenschr; 2001 May; 126(18):A403. PubMed ID: 11381643 [No Abstract] [Full Text] [Related]
11. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer. Rose K Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288 [TBL] [Abstract][Full Text] [Related]
12. [Children on the drug development map. The Danish Society of Clinical Pharmacology]. Thirstrup S; Heisterberg J; Ugeskr Laeger; 2008 Mar; 170(12):1039. PubMed ID: 18397657 [No Abstract] [Full Text] [Related]
13. [New EU law--an improvement for Norwegian children?]. Kalikstad B Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1770-2. PubMed ID: 19756062 [No Abstract] [Full Text] [Related]
14. Changing requirements for evaluation of pharmacologic agents. Chesney RW; Christensen ML Pediatrics; 2004 Apr; 113(4 Suppl):1128-32. PubMed ID: 15060209 [TBL] [Abstract][Full Text] [Related]
15. Something is moving in European drug research for children, but a more focused effort concerning all therapeutic needs is necessary. Pandolfini C; Bonati M Arch Dis Child; 2008 Aug; 93(8):715. PubMed ID: 18644943 [No Abstract] [Full Text] [Related]